Zdrowie i gospodarka · 07/11/2001
FDA Releases Revised Guidance on Stability Testing for New Pharmaceuticals
The FDA has released a revised guidance on stability testing for new pharmaceuticals, developed under the International Conference on Harmonisation, to provide clearer recommendations for EU, Japan, and US registration applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →